HIGHLIGHTS
- who: Ting Li from the The bioequivalence study has been registered on ClinicalTrialsgov (No.: NCT04885660, retrospectively registered in, ) and been approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University on August, (No.: QYFYEC, ). The study was performed at Phase I Clinical Research Center of the Affiliated Hospital of Qingdao University and was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice (GCP) and applicable laws and regulations of China National Medical Products Administration (NMPA).Written informed consent was obtained from all subjects before their participation in the study. Study design have . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.